Regulatory Updates
Sep 20, 2026•1 min read
K‑Beauty Pushes for Global Regulatory Harmonization
South Korea, now the world’s second‑largest cosmetics exporter, is focusing on aligning international regulations to avoid new trade hurdles as AI and biotech integrate into products.
Regulatory Updates
Sep 7, 2026•1 min read
Korean Pharma & Bio Leaders Call for Next‑Gen Modalities, AI Integration and Regulatory Reform
At CPHI Korea 2026, experts urged Korean pharma and biotech firms to secure next‑generation modalities, fuse physical AI, and expedite preclinical and data legislation updates.
Regulatory Updates
Sep 3, 2026•1 min read
China’s Fast‑Follower Model Pressures Biotech IP Strategies
Intensifying global drug development competition highlights the need for strong patents, timed disclosures and strategic workarounds as China’s fast‑follower biotech sector accelerates patient recruitment and cuts clinical costs.
Regulatory Updates
Aug 24, 2026•1 min read
PMCPA Rebukes Alnylam After Pfizer Complaint; UK Watchdog Overturns
Pfizer complained about Alnylam’s promotional activities at a cardiology congress, prompting the PMCPA to criticize the biotech, but the UK marketing watchdog later reversed its harshest finding on appeal.